$KREF
KKR Real Estate Finance Trust Inc.

2020 Q1 Form 10-Q Financial Statement

#000163159620000015 Filed on April 28, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $69.54M $66.70M
YoY Change 4.26% 63.12%
Cost Of Revenue $39.08M $34.84M
YoY Change 12.17% 225.91%
Gross Profit $30.46M $31.86M
YoY Change -4.39% 5.5%
Gross Profit Margin 43.8% 47.77%
Selling, General & Admin $8.280M $6.780M
YoY Change 22.12% 2.73%
% of Gross Profit 27.18% 21.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $9.680M $7.601M
YoY Change 27.35% 15.13%
Operating Profit $20.78M $24.26M
YoY Change -14.34% 2.8%
Interest Expense $39.08M $34.84M
YoY Change 12.17% 225.93%
% of Operating Profit 188.08% 143.63%
Other Income/Expense, Net -$1.541M $1.949M
YoY Change -179.07% -78.81%
Pretax Income -$34.49M $24.26M
YoY Change -242.19% 2.78%
Income Tax $82.00K $9.000K
% Of Pretax Income 0.04%
Net Earnings -$34.57M $24.25M
YoY Change -242.58% 3.66%
Net Earnings / Revenue -49.72% 36.35%
Basic Earnings Per Share -$0.61 $0.43
Diluted Earnings Per Share -$0.61 $0.43
COMMON SHARES
Basic Shares Outstanding 57.35M shares 57.39M shares
Diluted Shares Outstanding 57.35M shares 57.48M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $369.9M $228.4M
YoY Change 61.95% 888.74%
Cash & Equivalents $369.9M $228.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $17.30M $15.40M
Other Receivables $0.00 $0.00
Total Short-Term Assets $387.2M $243.8M
YoY Change 58.82% 664.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $34.40M $32.70M
YoY Change 5.2% 78.69%
Other Assets $3.100M
YoY Change
Total Long-Term Assets $5.068B $4.850B
YoY Change 4.5% -35.95%
TOTAL ASSETS
Total Short-Term Assets $387.2M $243.8M
Total Long-Term Assets $5.068B $4.850B
Total Assets $5.456B $5.094B
YoY Change 7.1% -33.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.400M $4.300M
YoY Change 25.58% 38.71%
Accrued Expenses $11.00M $1.126B
YoY Change -99.02% -78.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $45.60M $1.161B
YoY Change -96.07% -77.62%
LONG-TERM LIABILITIES
Long-Term Debt $4.378B $2.802B
YoY Change 56.23% 105.41%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $4.378B $2.802B
YoY Change 56.23% 105.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.60M $1.161B
Total Long-Term Liabilities $4.378B $2.802B
Total Liabilities $4.423B $3.963B
YoY Change 11.61% -39.52%
SHAREHOLDERS EQUITY
Retained Earnings -$8.594M -$281.0K
YoY Change 2958.36% -103.37%
Common Stock $575.0K $574.0K
YoY Change 0.17% 8.1%
Preferred Stock
YoY Change
Treasury Stock (at cost) $55.20M $35.96M
YoY Change 53.52% 189.17%
Treasury Stock Shares
Shareholders Equity $1.030B $1.129B
YoY Change
Total Liabilities & Shareholders Equity $5.456B $5.094B
YoY Change 7.1% -33.02%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$34.57M $24.25M
YoY Change -242.58% 3.66%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $27.38M $25.61M
YoY Change 6.89% 41.72%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$154.6M $236.5M
YoY Change -165.37% -161.86%
Cash From Investing Activities -$154.6M $236.5M
YoY Change -165.37% -161.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $23.25M $4.106M
YoY Change 466.29% -65.55%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $429.5M -$120.2M
YoY Change -457.27% -142.36%
NET CHANGE
Cash From Operating Activities $27.38M $25.61M
Cash From Investing Activities -$154.6M $236.5M
Cash From Financing Activities $429.5M -$120.2M
Net Change In Cash $302.2M $141.9M
YoY Change 112.99% -276.51%
FREE CASH FLOW
Cash From Operating Activities $27.38M $25.61M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2018Q4 kref Collateralized Loan Obligations Reinvestment Feature Term
CollateralizedLoanObligationsReinvestmentFeatureTerm
P2Y
CY2019Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.274
CY2019Q4 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.257
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2019Q4 kref Mortgage Loanson Real Estate Total Exposure
MortgageLoansonRealEstateTotalExposure
143600000 USD
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001631596
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55838032 shares
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2019Q4 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
2.9
CY2020Q1 kref Weighted Average Loan Risk Rating
WeightedAverageLoanRiskRating
3.0
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
57486583 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55838032 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
57486583 shares
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 USD
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2019Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1862689 shares
CY2020Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3511240 shares
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-38082
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
KKR Real Estate Finance Trust Inc.
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2009094
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
9 West 57th Street,
CY2020Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4200
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York,
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10019
CY2020Q1 dei City Area Code
CityAreaCode
212
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
750-8300
CY2020Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.01 per share
CY2020Q1 dei Trading Symbol
TradingSymbol
KREF
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55478573 shares
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
369867000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67619000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
65979000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
5089968000 USD
CY2019Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
4931042000 USD
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
5023989000 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
4931042000 USD
CY2020Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
34441000 USD
CY2019Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
37469000 USD
CY2020Q1 us-gaap Interest Receivable
InterestReceivable
17263000 USD
CY2019Q4 us-gaap Interest Receivable
InterestReceivable
16305000 USD
CY2020Q1 us-gaap Other Assets
OtherAssets
10121000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
4583000 USD
CY2020Q1 us-gaap Assets
Assets
5455681000 USD
CY2019Q4 us-gaap Assets
Assets
5057018000 USD
CY2020Q1 us-gaap Secured Debt
SecuredDebt
3368329000 USD
CY2019Q4 us-gaap Secured Debt
SecuredDebt
2884887000 USD
CY2020Q1 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
805008000 USD
CY2019Q4 kref Collateralized Loan Obligations Net
CollateralizedLoanObligationsNet
803376000 USD
CY2020Q1 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
139420000 USD
CY2019Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
139075000 USD
CY2020Q1 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
64972000 USD
CY2019Q4 us-gaap Participating Mortgage Loans Participation Liabilities Amount
ParticipatingMortgageLoansParticipationLiabilitiesAmount
64966000 USD
CY2020Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
24204000 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
25036000 USD
CY2020Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7513000 USD
CY2019Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
6686000 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
8907000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3363000 USD
CY2020Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
5022000 USD
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
5917000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
4423375000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
3933306000 USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
2108000 USD
CY2019Q4 us-gaap Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
1694000 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
575000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
575000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1167602000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1165995000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-82777000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8594000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
55202000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
35958000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030198000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1122018000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1030198000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1122018000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5455681000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5057018000 USD
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
71079000 USD
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
64751000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
39082000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
34842000 USD
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
31997000 USD
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
29909000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1901000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1125000 USD
CY2020Q1 kref Variable Interest Entity Changein Net Assets
VariableInterestEntityChangeinNetAssets
0 USD
CY2019Q1 kref Variable Interest Entity Changein Net Assets
VariableInterestEntityChangeinNetAssets
-342000 USD
CY2020Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
360000 USD
CY2019Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
482000 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1541000 USD
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1949000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3767000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2361000 USD
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
55274000 USD
CY2019Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
0 USD
CY2020Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
4299000 USD
CY2019Q1 kref Management Fees To Affiliate
ManagementFeesToAffiliate
4287000 USD
CY2020Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
1606000 USD
CY2019Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
953000 USD
CY2020Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
64946000 USD
CY2019Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7601000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-34490000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24257000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-34572000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
24248000 USD
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2020Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
592000 USD
CY2019Q1 kref Preferred Stock Redemption Adjustment And Dividends Income Statement Impact
PreferredStockRedemptionAdjustmentAndDividendsIncomeStatementImpact
-457000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35164000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
24705000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57346726 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57387386 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57346726 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57477234 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-34572000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
24248000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5388000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4377000 USD
CY2020Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
4333000 USD
CY2019Q1 kref Accretion Of Deferred Loan Costs And Discounts
AccretionOfDeferredLoanCostsAndDiscounts
6464000 USD
CY2020Q1 kref Variable Interest Entities Changein Noncash Assets
VariableInterestEntitiesChangeinNoncashAssets
0 USD
CY2019Q1 kref Variable Interest Entities Changein Noncash Assets
VariableInterestEntitiesChangeinNoncashAssets
154000 USD
CY2020Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
-2789000 USD
CY2019Q1 kref Increase Decreasein Equity Method Investments
IncreaseDecreaseinEquityMethodInvestments
468000 USD
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
55274000 USD
CY2019Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
0 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1607000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
991000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
958000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-724000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
687000 USD
CY2019Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-470000 USD
CY2020Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
827000 USD
CY2019Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1019000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1895000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
546000 USD
CY2020Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
146000 USD
CY2019Q1 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
14000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
27376000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25611000 USD
CY2020Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
179553000 USD
CY2019Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
561815000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
236506000 USD
CY2020Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
334146000 USD
CY2019Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
323539000 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1770000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154593000 USD
CY2019Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1258000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
157000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
805967000 USD
CY2019Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
335708000 USD
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24719000 USD
CY2019Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24899000 USD
CY2020Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
303000 USD
CY2019Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
271000 USD
CY2020Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
324825000 USD
CY2019Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
424665000 USD
CY2020Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2206000 USD
CY2019Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
717000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
23252000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4106000 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1040000 USD
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
429465000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-120208000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
302248000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
141909000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67619000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
86531000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
369867000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
228440000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
33376000 USD
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
30834000 USD
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2019Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
127000 USD
CY2020Q1 us-gaap Dividends
Dividends
24204000 USD
CY2019Q1 us-gaap Dividends
Dividends
24850000 USD
CY2020Q1 kref Deferred Finance Costs Incurred But Not Yet Paid
DeferredFinanceCostsIncurredButNotYetPaid
86000 USD
CY2019Q1 kref Deferred Finance Costs Incurred But Not Yet Paid
DeferredFinanceCostsIncurredButNotYetPaid
0 USD
CY2020Q1 kref Deferred Issuance Costs Not Yet Paid
DeferredIssuanceCostsNotYetPaid
101000 USD
CY2019Q1 kref Deferred Issuance Costs Not Yet Paid
DeferredIssuanceCostsNotYetPaid
0 USD
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </span><span style="font-family:inherit;font-size:10pt;">— The preparation of condensed consolidated financial statements in conformity with </span><span style="font-family:inherit;font-size:10pt;">GAAP</span><span style="font-family:inherit;font-size:10pt;"> requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Management makes subjective estimates to project cash flows </span><span style="font-family:inherit;font-size:10pt;">KREF</span><span style="font-family:inherit;font-size:10pt;"> expects to receive on its investments in loans and securities as well as the related market discount rates, which significantly impacts the interest income, impairments, allowance for loan loss and fair values recorded or disclosed. The effects of COVID-19 may negatively and materially impact significant estimates and assumptions used by the Company including, but not limited to estimates of expected credit losses, valuation of our equity method investments and the fair value estimates of the Company’s assets and liabilities</span><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">. </span><span style="font-family:inherit;font-size:10pt;">Actual results could materially differ from those estimates.</span></div>
CY2020Q1 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
50400000 USD
CY2019Q4 kref Debt Instrument Covenant Liquidity Required Cashand Cash Equivalents
DebtInstrumentCovenantLiquidityRequiredCashandCashEquivalents
33400000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
4931042000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
0 USD
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
4931042000 USD
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
3363000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8594000 USD
CY2020Q1 kref Accrued Share Buybacks
AccruedShareBuybacks
4000000.0 USD
CY2020Q1 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
3100000 USD
CY2019Q4 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
2400000 USD
CY2020Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
3500000 USD
CY2020Q1 us-gaap Deposits
Deposits
1200000 USD
CY2019Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
2700000 USD
CY2019Q4 us-gaap Deposits
Deposits
700000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2020Q1 us-gaap Notes Receivable Net
NotesReceivableNet
5023989000 USD
CY2020Q1 kref Prepayment Penalties
PrepaymentPenalties
0.0 USD
CY2019Q4 us-gaap Notes Receivable Net
NotesReceivableNet
4931042000 USD
CY2020Q1 us-gaap Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
334146000 USD
CY2020Q1 srt Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
179553000 USD
CY2020Q1 kref Mortgage Loanson Real Estate Amortizationof Premium Discount Net
MortgageLoansonRealEstateAmortizationofPremiumDiscountNet
-4333000 USD
CY2020Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
5089968000 USD
CY2020Q1 kref Net Accelerated Fees
NetAcceleratedFees
200000 USD
CY2019Q1 kref Prepayment Penalties
PrepaymentPenalties
200000 USD
CY2019Q1 kref Net Accelerated Fees
NetAcceleratedFees
2300000 USD
CY2020Q1 kref Mortgage Loanson Real Estate Total Exposure
MortgageLoansonRealEstateTotalExposure
143600000 USD
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
55300000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8000000.0 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9500000 USD
CY2020Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateral
0.274
CY2020Q1 kref Debt Instrument Average Haircut Weightedby Outstanding Face Amountof Collateral Percentageif Maximum Amountis Borrowed
DebtInstrumentAverageHaircutWeightedbyOutstandingFaceAmountofCollateralPercentageifMaximumAmountisBorrowed
0.257
CY2020Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
721178000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
436116000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1272341000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
737913000 USD
CY2020Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
212309000 USD
CY2020Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3379857000 USD
CY2020Q1 kref Debt Instrument Covenant Interest Incometo Interest Expense Ratio
DebtInstrumentCovenantInterestIncometoInterestExpenseRatio
1.5
CY2020Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Minimum Percentageof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthMinimumPercentageofAggregateCashProceedsMadeandCapitalContributionsReceived
0.750
CY2020Q1 kref Debt Instrument Covenant Consolidated Tangible Net Worth Amountof Aggregate Cash Proceeds Madeand Capital Contributions Received
DebtInstrumentCovenantConsolidatedTangibleNetWorthAmountofAggregateCashProceedsMadeandCapitalContributionsReceived
880200000 USD
CY2020Q1 kref Debt Instrument Covenant Cash Liquidity Amount
DebtInstrumentCovenantCashLiquidityAmount
10000000.0 USD
CY2020Q1 kref Debt Instrument Covenant Cash Liquidity Percentof Recourse Indebtedness
DebtInstrumentCovenantCashLiquidityPercentofRecourseIndebtedness
0.050
CY2020Q1 kref Debt Instrument Covenant Total Indebtedness Percentof Total Assets
DebtInstrumentCovenantTotalIndebtednessPercentofTotalAssets
0.750
CY2020Q1 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.195
CY2019Q4 kref Collateral Assets Under Collateralized Loan Obligations As A Percentage Of Commercial Mortgage Loans
CollateralAssetsUnderCollateralizedLoanObligationsAsAPercentageOfCommercialMortgageLoans
0.202
CY2020Q1 kref Percentage Of Collateralized Loan Obligations Under Floating Rate Loans
PercentageOfCollateralizedLoanObligationsUnderFloatingRateLoans
1
CY2020Q1 kref Number Of Equity Method Investments
NumberOfEquityMethodInvestments
2 investment
CY2014Q4 kref Common Stockand Preferred Stock Shares Authorized
CommonStockandPreferredStockSharesAuthorized
350000000 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2016Q1 kref Common Stock Value Per Limited Liability Company Interest Allocation
CommonStockValuePerLimitedLiabilityCompanyInterestAllocation
100000000.0 USD
CY2020Q1 kref Treasury Stock Accumulated Shares Acquired
TreasuryStockAccumulatedSharesAcquired
3511240 shares
CY2019Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000.0 USD
CY2019Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50000000.0 USD
CY2019Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50000000.0 USD
CY2019 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
212809 shares
CY2019 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
19.25
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4100000 USD
CY2020Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1648551 shares
CY2020Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
11.64
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19200000 USD
CY2020Q1 kref Treasury Stock Shares Acquired Subsequently Settled
TreasuryStockSharesAcquiredSubsequentlySettled
262492 shares
CY2020Q1 kref Treasury Stock Acquired Average Cost Per Share Subsequently Settled
TreasuryStockAcquiredAverageCostPerShareSubsequentlySettled
15.24
CY2020Q1 kref Treasury Stock Value Acquired Cost Method Subsequently Settled
TreasuryStockValueAcquiredCostMethodSubsequentlySettled
4000000.0 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24010000 USD
CY2020Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24010000 USD
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.43
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24761000 USD
CY2019Q1 us-gaap Dividends Common Stock
DividendsCommonStock
24761000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35164000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
24705000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57346726 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57387386 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
0 shares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Accelerated Share Repurchase Agreements
IncrementalCommonSharesAttributableToAcceleratedShareRepurchaseAgreements
89848 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57346726 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57477234 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2020Q1 kref Sharebased Compensation Arrangementby Sharebased Payment Award Issuance Ratio
SharebasedCompensationArrangementbySharebasedPaymentAwardIssuanceRatio
1
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y2M12D
CY2020Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
5022000 USD
CY2019Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
5917000 USD
CY2020Q1 us-gaap Noninterest Expense Related To Performance Fees
NoninterestExpenseRelatedToPerformanceFees
1606000 USD
CY2020Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
6204000 USD
CY2019Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5605000 USD
CY2020Q1 kref Mortgage Loanson Real Estate Unamortized Discountsand Deferred Fees
MortgageLoansonRealEstateUnamortizedDiscountsandDeferredFees
28200000 USD
CY2019Q4 kref Mortgage Loanson Real Estate Unamortized Discountsand Deferred Fees
MortgageLoansonRealEstateUnamortizedDiscountsandDeferredFees
29700000 USD
CY2020Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
770497000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0.0 USD
CY2020Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2020-03-31

Files In Submission

Name View Source Status
0001631596-20-000015-index-headers.html Edgar Link pending
0001631596-20-000015-index.html Edgar Link pending
0001631596-20-000015.txt Edgar Link pending
0001631596-20-000015-xbrl.zip Edgar Link pending
a202003-exhibit311.htm Edgar Link pending
a202003-exhibit312.htm Edgar Link pending
a202003-exhibit321.htm Edgar Link pending
a202003-exhibit322.htm Edgar Link pending
a202003-kref10q.htm Edgar Link pending
a202003-kref10q_htm.xml Edgar Link completed
ex10_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kref-20200331.xsd Edgar Link pending
kref-20200331_cal.xml Edgar Link unprocessable
kref-20200331_def.xml Edgar Link unprocessable
kref-20200331_lab.xml Edgar Link unprocessable
kref-20200331_pre.xml Edgar Link unprocessable
kreflogoa20.jpg Edgar Link pending
krefpiechartsvhorizontal1q24.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending